Drug Information

Drug General Information
Drug ID
D07HSQ
Former ID
DNC007096
Drug Name
1-adamantan-1-yl-3-((R)-1-phenyl-ethyl)-urea
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528417]
Structure
Download
2D MOL

3D MOL
Formula
C19H26N2O
Canonical SMILES
CC(C1=CC=CC=C1)NC(=O)NC23CC4CC(C2)CC(C4)C3
InChI
1S/C19H26N2O/c1-13(17-5-3-2-4-6-17)20-18(22)21-19-10-14-7-15(11-19)9-16(8-14)12-19/h2-6,13-16H,7-12H2,1H3,(H2,20,21,22)/t13-,14?,15?,16?,19?/m1/s1
InChIKey
ODVZFEPLOWORBJ-PGBRGIIUSA-N
PubChem Compound ID
44419692
Target and Pathway
Target(s) Soluble epoxide hydrolase Target Info Inhibitor [528417]
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
Peroxisome
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Metapathway biotransformation
Arachidonate Epoxygenase / Epoxide Hydrolase
Arachidonic acid metabolism
References
Ref 528417Bioorg Med Chem Lett. 2006 Nov 15;16(22):5773-7. Epub 2006 Sep 1.Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.
Ref 528417Bioorg Med Chem Lett. 2006 Nov 15;16(22):5773-7. Epub 2006 Sep 1.Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.